SOPHARMA AD: NOTIFICATION

opublikowano: 2015-02-05 14:08

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
Sopharma_monthly_Januari_2015.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 15 / 2015
Date of issue: 2015-02-05
Short name of the issuer
SOPHARMA AD
Subject
NOTIFICATION
Official market - legal basis
Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieї№ce i okresowe
Unofficial market - legal basis
Contents of the report:
Sopharma AD notifies that for January 2015 the Company recorded a decrease of sales revenues of 43% compared to the same month of 2014, including 11% increase of domestic sales and 61% decrease of export sales. The volatility of the RUB caused us to undertake actions to adjust the prices for our main export market - Russia, which prevented us from exporting during the period.
Our forecast is that this slowdown in the beginning of the year will be compensated already in the first quarter.
Annexes
File Description
Sopharma monthly Januari 2015.docSopharma monthly Januari 2015.doc Sopharma monthly Januari 2015

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2015-02-05 Ognian Ivanov Donev Executive Director